| | ANC category | Recommended/current ANC characteristics | Proposed ANC characteristics |
| | Personal information (PI) | Name, name of partner/husband, date of birth, address, contact number, educational background, occupation, religion, maternal age, date of the first registration/visit, ownership of health insurance, ownership of Maternal and Child Health (MCH) booklet, prepregnancy weight, prepregnancy height, and blood type. | Ethnicity/country of birth and prepregnancy body mass index (BMI). |
| | Obstetric history (OH) | Gravidity, parity, number of deliveries, number of abortions, number of live births, obstetric complication history, chronic diseases and allergies, the last delivery date, the last menstrual period, and the estimated delivery date. | Number of stillbirths, number of premature births, prepregnancy contraception, distance between previous and current pregnancies, the last birth attendance, the last tetanus toxoid (TT) immunisation, and the last mode of delivery. |
| | Delivery plans (DP) | Birth attendance, birth place, birth companion, transportation, and blood donor. | - |
| | Antenatal care utilisation criteria (ANCUC) | Gestational age (GA), the method of antenatal care (ANC) enrolment, date of consultation, and date of the next consultation. | Number of antenatal care (ANC) visits. |
| | Maternal measurements (MM) | Anamnesis, patellar reflex, weight, middle upper arm circumference (MUAC), nutritional status, blood pressure, and fundal height (FH). | Height, body mass index (BMI), body temperature, blood pressure (column separation between systole and diastole records), pulse, breathe, and abdominal palpation (Leopold I, II, III, and IV). |
| | Laboratory tests (LT) | Haemoglobin level, urine protein, syphilis, maternal urine reduction, blood sugar level, thalassemia, hepatitis B surface antigen, prevention of mother to child transmission (human immunodeficiency virus (HIV) test), rapid test (malaria), and tuberculosis. | Haemoglobin level: before and after having iron tablets, sputum acid resistant bacteria, and ankylostoma test. |
| | Supplements (S) | Iron tablets and tetanus toxoid (TT) immunisation. | Folic acid, calcium, aspirin, and vitamin C. |
| | Maternal risk detection (MRD) | Maternal complication, referral, and risk detector. | Intervention action. |
| | Foetal measurements: clinical method (CFM) | Number of gestation, foetal weight estimation, foetal heart rate, foetal presentation, and foetal station/descent level (FS). | - |
| | Foetal measurements: ultrasonic method (UFM) | Not available | Gestational age (GA) based on ultrasound scanning, crown-rump length, head circumference, abdominal circumference, biparietal diameter, femur length, humerus length, placenta localisation, foetal presentation, amniotic fluid index, foetal heart rate, and foetal weight estimation. |
| | Foetal risk detection (FRD) | Not available | Foetal complication, intervention action, referral, and risk detector. |
| | Delivery time (DT) | Gestational age (GA) at delivery time, last menstrual period age at delivery time, active phase I and II (date and time), active phase III management, breast feeding initiation, neonatal delivery (date and time), placenta delivery (date and time), new born gender, new born presentation, birth weight, birth length, head circumference, birth place and address, delivery complication, referral, birth attendance, integration programs, bleeding status, mode of delivery, and survival status (mother and new born). | Abdominal circumference, chest circumference, femur length, humerus length, and intervention action towards delivery complications. |
|
|
